Simplified Summary
Recombinant human growth hormone is a single-chain polypeptide produced by somatotroph cells of the anterior pituitary gland and widely used in laboratory research as a reference standard and pharmacological tool for studying GH biology. Preclinical research has employed rhGH to characterise growth hormone receptor signalling through the JAK2-STAT5 pathway, downstream IGF-1 production in liver and peripheral tissues, and the tissue-specific anabolic and metabolic consequences of GH receptor activation.
In preclinical metabolic research, growth hormone has been studied for its complex role in regulating lipolysis, protein synthesis, and carbohydrate metabolism in animal models. Laboratory investigations have characterised how GH promotes fatty acid mobilisation from adipose tissue while stimulating protein anabolism in skeletal muscle, and how these effects interact with insulin signalling in models of metabolic regulation.
Key Findings Reported in Preclinical Models
- Growth hormone receptor binding and JAK2-STAT5 signalling cascade characterisation in cell-based and animal model systems.
- IGF-1 production stimulation in liver tissue following GH receptor activation, with preclinical models characterising the GH-liver-IGF-1 axis.
- Promotion of lipolysis in adipose tissue with concomitant stimulation of protein synthesis in skeletal muscle in animal model metabolic studies.
- Effects on linear bone growth in preclinical rodent and animal models through IGF-1-mediated chondrocyte proliferation at growth plates.
- Modulation of insulin sensitivity in preclinical metabolic models, with GH-associated changes in glucose metabolism characterised in relevant animal model systems.
Introduction
Growth hormone is one of the most extensively studied peptide hormones in endocrinology research, with preclinical investigations spanning receptor biology, metabolic regulation, growth physiology, and ageing biology. Recombinant human GH produced for laboratory research applications has been instrumental in characterising the molecular and physiological consequences of GH receptor activation across diverse tissue types in animal model systems.
Research Applications
- GH receptor signalling research in cell culture and animal models characterising JAK2-STAT5 pathway activation and downstream gene expression consequences.
- Body composition and anabolic biology research in preclinical models examining GH-mediated effects on muscle protein synthesis and adipose tissue lipolysis.
- Metabolic regulation research examining interactions between growth hormone signalling and insulin sensitivity in relevant animal model systems.
- Ageing and somatopause biology research investigating the consequences of declining GH axis activity and the effects of GH supplementation in older animal model cohorts.
For research use only. Capital Peptides products are not approved by the TGA for therapeutic use. By purchasing you confirm you are a licensed research entity or qualified professional.